Association between adiponectin concentrations and diabetic retinopathy in patients with type 2 diabetes: A meta analysis

Chinese Medical Journal

Volumn 127, Issue 4, 2014, Pages 765-771

  Fan, Xiao Hong ^a,b   Wu, Qun Hong ^a   Yuan, Li ^e   Hao, Yan Hua ^a   Ning, Ning ^a   Zheng, Kang ^a   Yu, Cui ^a   Liu, Ruo Hong ^d   Han, Li Yuan ^c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Fourth Hospital of Harbin City   (China)

^c NINGBO UNIVERSITY   (China)

^d Wenhua Community Clinics   (China)

^e NONE

Author keywords

Adiponectin concentrations; Diabetic retinopathy; Meta analysis; Type 2 diabetic mellitus

Indexed keywords

ADIPONECTIN;

BLOOD; COMPLICATION; DIABETIC RETINOPATHY; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADIPONECTIN; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY;

EID: 84894070343     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20132507     Document Type: Article

References (58)

1. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diab Care 2012; 35: 556-564.
2. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996; 221: 286-289.
3. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746-26749.
4. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adiposespecific gene dysregulated in obesity. J Biol Chem 1996; 271: 10697-10703.
5. Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem 1996; 120: 803-812.
6. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002; 13: 84-89.
7. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003; 148: 293-300.
8. Ukkola O, Santaniemi M. Adiponectin: a link between excess adiposity and associated comorbidities. J Mol Med 2002; 80: 696-702.
9. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83.
10. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adiposespecific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599.
11. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23: 85-89.
12. Goldstein BJ, Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 2004; 89: 2563-2568.
13. Higuchi A, Ohashi K, Kihara S, Walsh K, Ouchi N. Adiponectin suppresses pathological microvessel formation in retina through modulation of tumor necrosis factor-alpha expression. Circ Res 2009; 104: 1058-1065.
14. Bora PS, Kaliappan S, Lyzogubov VV, Tytarenko RG, Thotakura S, Viswanathan T, et al. Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin. FEBS Lett 2007; 581: 1977-1982.
15. Omae T, Nagaoka T, Tanano I, Yoshida A. Adiponectin-induced dilation of isolated porcine retinal arterioles via production of nitric oxide from endothelial cells. Invest Ophthalmol Vis Sci 2013; 54: 4586-4594.
16. Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007; 2007: 95103.
17. Shimabukuro M, Higa N, Asahi T, Oshiro Y, Takasu N, Tagawa T, et al. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 2003; 88: 3236-3240.
18. Yilmaz MI, Sonmez A, Acikel C, Celik T, Bingol N, Pinar M, et al. Adiponectin may play a part in the pathogenesis of diabetic retinopathy. Eur J Endocrinol 2004; 151: 135-140.
19. Matsuda M, Kawasaki F, Yamada K, Kanda Y, Saito M, Eto M, et al. Impact of adiposity and plasma adipocytokines on diabetic angiopathies in Japanese type 2 diabetic subjects. Diabet Med 2004; 21: 881-888.
20. Kato K, Osawa H, Ochi M, Kusunoki Y, Ebisui O, Ohno K, et al. Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy. Clin Endocrinol 2008; 68: 442-449.
21. Crawford TN, Alfaro DV 3rd, Kerrison JB, Jablon EP. Diabetic retinopathy and angiogenesis. Curr Diabetes Rev 2009; 5: 8-13.
22. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
23. Martin B. Meta-analysis: dealing with heterogeneity. York: University of York 2006; 6.
24. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in metaanalysis. Biometrics 2000; 56: 455-463.
25. Choe EY, Wang HJ, Kwon O, Kim KJ, Kim BS, Lee BW, et al. Variants of the adiponectin gene and diabetic microvascular complications in patients with type 2 diabetes. Metabolism 2013; 62: 677-685.
26. Mao D, Peng H, Li Q, Wang J, Li P, Hu K, et al. Aqueous humor and plasma adiponectin levels in proliferative diabetic retinopathy patients. Curr Eye Res 2012; 37: 803-808.
27. Zietz B, Buechler C, Kobuch K, Neumeier M, Scholmerich J, Schaffler A. Serum levels of adiponectin are associated with diabetic retinopathy and with adiponectin gene mutations in Caucasian patients with diabetes mellitus type 2. Exp Clin Endocrinol Diabetes 2008; 116: 532-536.
28. Bai LN, Zhang XD. The relationship between adiponectin and diabetic retinopathy in Chinese. Chongqing Medical University 2007.
29. Gu L, Yao XL. The association between adiponectin and diabetic retinopathy (in Chinese). China Pract Diag Treat Dis 2009; 24: 334-336
30. Jiang HB, Shi YX, Lin JY, Li YJ, Tao G. Adiponectin in patients with type 2 diabetes and association with retinopathy (in Chinese). China Pract Med 2010; 5: 9-11.
31. Sang HY, Zhang SW. The relationship between serum adiponectin, TNF alpha and type 2 diabetic retinopathy (in Chinese). Dalian Med Univ 2006.
32. Zhang Y, Wang SM. The relationship between Serum adiponectin level and type 2 diabetic retinopathy (in Chinese). Shandong Univ 2009.
33. Zhao T, Wu YS. Serum adiponectin level and the correlation with diabetic retinopathy (in Chinese). China Healthcare Innov 2010; 5: 7-8.
34. Zhou XH, Guo KJ. The research of serum adiponectin level and type 2 diabetic retinopathy (in Chinese). Lab Clin Med 2007; 4: 938-940.
35. Shen HJ, Li JM.The correlation of adiponectin, leptin and of type 2 diabetic retinopathy (in Chinese). Dalian Med Univ 2011.
36. Li CL, Pang Y, Li SD, Liu W. Serum adiponectin and leptin levels in the diagnosis of early diabetic retinopathy (in Chinese). Doctor Pharmacy 2012;10: 107
37. Liu Y, Liu D. The research of serum adiponectin level, PAI-1 and diabetic retinopathy (in Chinese). Shandong Med 2011; 51: 41-43.
38. Yu CQ, Lin P, Liu ZJ. The significance changes of serum APN and hs-CRP in diabetic retinopathy patients (in Chinese). J Qingdao Med Univ 2011; 47: 510-511.
39. Wang XL. The change of serum adiponectin and hs-CRP in type 2 diabetic patients with retinopathy (in Chinese). Int J Ophthal 2010; 10: 1699-1700.
40. Xu J. The relationship between serum adiponectin levels and type 2 diabetic retinopaty (in Chinese). China Modern Med 2012; 19: 29-30.
41. Wan H, Yao WF, Qian TY. The analysis of CAMS and serum adiponectin levels in patients with diabetic retinopathy (in Chinese). Youjiang Med J 2007; 35: 629-631.
42. Zhang W, Liu H, Al-Shabrawey M, Caldwell RW, Caldwell RB. Inflammation and diabetic retinal microvascular complications. J Cardiovasc Dis Res 2011; 2: 96-103.
43. Li FY, Cheng KK, Lam KS, Vanhoutte PM, Xu A. Cross-talk between adipose tissue and vasculature: role of adiponectin. Acta Physiol 2011; 203: 167-180.
44. Thundyil J, Pavlovski D, Sobey CG, Arumugam TV. Adiponectin receptor signalling in the brain. Br J Pharmacol 2012; 165: 313-327.
45. Higuchi A, Ohashi K, Shibata R, Sono-Romanelli S, Walsh K, Ouchi N. Thiazolidinediones reduce pathological neovascularization in ischemic retina via an adiponectin-dependent mechanism. Arterioscler Thromb Vasc Biol 2010; 30: 46-53.
46. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adiposespecific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599.
47. Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study. Diab Care 2003; 26: 2015-2020.
48. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002; 360: 57-58.
49. Dastani Z, Hivert MF, Timpson N, Perry JR, Yuan X, Scott RA, et al. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet 2012; 8: e1002607.
50. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003; 278: 45021-45026.
51. Cheng KK, Lam KS, Wang Y, Huang Y, Carling D, Wu D, et al. Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells. Diabetes 2007; 56: 1387-1394.
52. Nagaoka T, Sakamoto T, Mori F, Sato E, Yoshida A. The effect of nitric oxide on retinal blood flow during hypoxia in cats. Invest Ophthalmol Vis Sci 2002; 43: 3037-3044.
53. Nagaoka T, Sato E, Takahashi A, Yokota H, Sogawa K, Yoshida A. Impaired retinal circulation in patients with type 2 diabetes mellitus: retinal laser Doppler velocimetry study. Invest Ophthalmol Vis Sci 2010; 51: 6729-6734.
54. Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese,and type 2 diabetic subjects. Diabetes 2002; 51: 2968-2974.
55. Frystyk J, Tarnow L, Hansen TK, Parving HH, Flyvbjerg A. Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 2005; 48: 1911-1918.
56. Hadjadj S, Aubert R, Fumeron F, Pean F, Tichet J, Roussel R, et al. Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects. Diabetologia 2005; 48: 1088-1092.
57. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 2003; 278: 40352-40363.
58. Goldstein BJ, Scalia RG, Ma XL. Protective vascular and myocardial effects of adiponectin. Nat Clin Pract Cardiovasc Med 2009; 6: 27-35.